MedTrace Logo

Optimizing Preoperative Disinfection of Eyes

NCT04745663 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2021-09-14

No results posted yet for this study

Summary

Topical povidone-iodine (PI) is widely used as ocular antiseptic before and after surgery. The standard dose of 5% PI is however, associated with ocular irritation. We therefore want to test if a lower concentration of PI can be similarly efficacious in reducing bacterial growth while reducing ocular irritation.

Conditions

  • Eye Infections

Interventions

DRUG

Povidone-Iodine 0.3%

Low concentration iodine

DRUG

Povidone-Iodine 5%

Standard concentration iodine

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Jorunn Helbostad, MD PhD · Norwegian University of Science and Technology

  • Marit Fagerli, MD · Clinic of Ear-Nose-Throat, Eye and Maxillofacial Surgery, St. Olavs Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745663 on ClinicalTrials.gov